52 results
8-K
EX-10.1
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
or prospects) or (b) the reputation of the Company or any of the Released Parties. A breach of this provision will be deemed to be a material breach
8-K
EX-10.2
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
) the reputation of the Company or any of the Released Parties. A breach of this provision will be deemed to be a material breach of this Agreement
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
, resulting in damage to Kineta’s reputation and business.
Kineta relies on third parties to conduct, supervise and monitor its clinical trials and perform … the market after obtaining marketing approval;
be subject to lawsuits; or
experience damage to Kineta’s reputation.
Conducting clinical trials
8-K
EX-10.6
im0ze6rvrfy4 tubrkmz
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
qa42n4vufu4
10 Nov 22
Prospectus supplement
4:21pm